IMM Immupharma Plc

 

TIDMIMM 
 
RNS Number : 1946U 
Immupharma PLC 
11 October 2010 
 

11 October 2010 
 
 
                                 Immupharma plc 
                   ADDITIONAL LISTING AND TOTAL VOTING RIGHTS 
                      PICTET INCREASE HOLDING TO OVER 3% 
 
ImmuPharma plc (LSE:IMM) ("Immupharma" or the "Company"), the specialist 
discovery and development pharmaceutical company announces that following the 
exercise of options held by the liquidators to Dawnay Day Corporate Finance 
Limited, application has been made to the London Stock Exchange for the 
admission of 441,000 new ordinary shares of 10 pence each in the Company to 
trading on AIM.  It is expected that these new ordinary shares, which will rank 
pari passu with the existing ordinary shares of the Company, will be admitted to 
trading on 12 October 2010. 
 
Following the allotment of the new ordinary shares, the Company's issued share 
capital will consist of 81,532,463 Ordinary Shares of 10p each which entitle the 
holder to one vote per share.  Therefore, the total number of voting rights is 
81,532,463. 
 
The above figure may be used by shareholders as the denominator for the 
calculations by which they will determine if they are required to notify their 
interest in, or a change to their interest in, the Company under the FSA's 
Disclosure and Transparency Rules. 
 
The Company is also pleased to announce that Pictet Overseas Trust Corporation 
Limited have increased their stake in Immupharma to 3.02%. 
 
Commenting on the developments, Chairman, Richard Warr, said: 
 
"We are delighted that Pictet have increased their shareholding in ImmuPharma in 
excess of 3% and are pleased to have the continued support of such a prestigious 
Swiss bank." 
 
For further information, please contact: 
ImmuPharma PLC: 
Dimitri Dimitriou, Chief Executive Officer 
+44 20 7152 4080 
Richard Warr, Chairman 
Tracy Weimar, VP, Operations 
 
Buchanan Communications 
Lisa Baderoon, Mark Court 
 +44 20 7466 5000 
 
Panmure, Gordon & Co., NOMAD & Broker 
Andrew Burnett 
       +44 20 7459 3600 
Rakesh Sharma 
 
Execution Noble & Co, Joint Broker 
James Bromhead 
    +44 20 7456 9191 
Richard Crawley 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 LISBXBDGDGBBGGB 
 

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024